Geneva, Aug. 29 -- International Clinical Trials Registry received information related to the study (NCT07118800) titled 'Study Evaluating Two Treatment Strategies for Rectal Cancer in Patients =75 Years Old' on Aug. 5.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).

Primary Sponsor: UNICANCER

Condition: Locally Advanced Rectal Adenocarcinoma

Intervention: Drug: FOLFOX4s

Recruitment Status: Not recruiting

Phase: Phase 3

Date of First Enrollment: December 15, 2025

Target Sample Size: 160

To know more, visit https://clinicaltrials.gov/ct2/show/NCT07118800

Disclaimer: Curated by HT Syndication....